Antihyperalgesic effect of the N-methyl D-aspartate receptor antagonist dextromethorphan in the oral surgery model

Journal of Clinical Pharmacology

Volumn 39, Issue 2, 1999, Pages 139-146

  Gordon, Sharon M ^a   Dubner, Ronald ^a   Dionne, Raymond A ^a,b  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTROMETHORPHAN; EXCITATORY AMINO ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE; PARACETAMOL;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERALGESIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; ORAL SURGERY; PAIN; RANDOMIZED CONTROLLED TRIAL;

ADULT; DOUBLE-BLIND METHOD; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; HYPERALGESIA; MALE; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; RECEPTORS, N-METHYL-D-ASPARTATE; STATISTICS, NONPARAMETRIC; TOOTH EXTRACTION;

EID: 0032957367     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912709922007688     Document Type: Article

References (47)

1. Dubner R: Neuronal plasticity and pain following peripheral tissue inflammation or nerve injury. In, Bond MR, Charlton JE, Woolf CJ (eds.): Proceedings of the VIth World Congress on Pain. New York: Elsevier, 1991;263-276.
2. Coderre TJ, Katz J, Vaccarino AL, Melzack R: Contribution of central neuorplasticity to pathological pain: a review of clinical and experimental evidence. Pain 1993;52:259-285.
3. Meller ST, Gebhardt GF: Spinal mediators of hyperalgesia. Drugs 1994;47(Suppl. 5):10-20.
4. 3H] gluatmate binding sites in rat brain. J Neurosci 1985;5:2909-2919.
5. Wilcockson WS, Chung JM, Hori Y, Lee KH, Willis WD: Effects of ionotophoretically released amino acids and amines on primate spinothalamic tract cells. J Neurosci 1984;4:732-740.
6. King AE, Thompson SWN, Urban L, Woolf CW: An intracellular analysis of amino acid induced excitations of deep dorsal horn neurones in the rat spinal cord slice. Neurosci Lett 1988;89:286-292.
7. Aanonsen LM, Lei S, Wilcox GL: Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain 1990;41:309-321.
8. Dougherty PM, Willis WD: Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P. Pain 1991;47:85-93.
9. Sher GD, Mitchell D: Intrathecal N-methyl-D-aspartate induces hyperexcitability in rat dorsal horn convergent neurones. Neurosci Lett 1990;119:199-202.
10. Dickenson AH, Sullivan AF: Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following C fibre stimulation. Neuropharmacology 1987;26:1235-1238.
11. Jeftinija S: Excitatory transmission in the dorsal horn is in part mediated through APV-sensitive NMDA receptors. Neurosci Lett 1989;96:191-196.
12. Haley JE, Sullivan AF, Dickenson AH: Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nocicepetion in the rat. Brain Res 1990;518:218-226.
13. Mendell LM: Physiological properties of unmyelinated fiber projections to the spinal cord. Exp Neurol 1966;16:316-332.
14. Davies SN, Lodge D: Evidence for involvement of N-methyl-aspartate receptors in "wind-up" of class 2 neurones in the dorsal horn of the rat. Brain Res 1987;424:401-406.
15. Dickenson AH, Sullivan AF: Subcutaneous formalin-induced activity of dorsal horn neurons in the rat: differential response to an intrathecal opiate administration pre-or post-formalin. Pain 1987;30:349-360.
16. Woolf CJ, Thompson SWM: The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991;44:293-299.
17. Ren K, Williams GM, Hylden JLK, Ruda MA, Dubner R: The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carageenan-induced behavior hyperalgesia in rats. European J Pharmacol 1992;219:235-243.
18. Dougherty PM, Palecek J, Paleckova V, Sorkin LS, Willis WD: The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. J Neurosci 1992;12:3025-3041.
19. Neugebauer V, Kornhuber J, Lucke T, Schaible H-G: The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal reurones. NeuroReport 1993;4:1259-1262.
20. Neugebauer V, Lucke T, Schaible H-G: Differential effects of N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists on the responses of rat spinal neurones with joint input. Neurosci Lett 1993;155:29-32.
21. Neugebauer V, Lucke T, Schaible H-G: N-methyl-D-aspartate (NMDA) and non-NMDA receptor antagonists block the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J Neurophysiol 1993;70:1365-1377.
22. Ren K, Dubner R: NMDA receptor antagonist attenuate mechanical hyperalgesia in rats with unilateral inflammation of the hindpaw. Neurosci Lett 1993;163:22-26.
23. Schaible H-G, Grubb BD, Neugebauer V, Oppmann M: The effects of NMDA antagonists on neuronal activity in cat spinal cord evoked by acute inflammation in the knee joint. Eur J Neurosci 1991;3:981-991.
24. Elliott KJ, Brodsky M, Hynansky AD, Foley KM, Inturrisi CE: Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA. Pain 1995;61:401-409.
25. Price DD, Mao J, Frenk H, Mayer D: The N-methyl-D-aspartate receptor antagonist dextromethorphan selectively reduces temporal summation of second pain in man. Pain 1994;59:165-174.
26. Seltzer Z, Cohn S, Ginzburg R, Beilin BZ: Modulation of neuropahtic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain 1991;45:69-75.
27. Aram JA, Martin D, Tomszyk M, Seman S, Millar J, Pohler G, Lodge D: Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands. J Pharmacol Exper Ther 1989;248:320-328.
28. Eide PK, Jorum E, Stubhaug A, Bremmes J, Breivik H: Relief of post herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine, a double-blind crossover comparison with morphine and placebo. Pain 1994;58:347-354.
29. Backonja M, Arndt G, Gombar K, Check B, Zimmermann M: Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994;58:347-354.
30. Max MB, Byas-Smith MG, Gracely RH, Bennett GJ: Intravenous infusion of the NMDA antagonist, ketamine, in chronic post-traumatic pain with allodynia: a double-blind comparison of alfentanil and placebo. Clin Neuropharmacol 1995;18:360-368.
31. Eide PK, Stubhaug A, Stenehjem AE: Central dysesthesia pain after traumatic spinal cord injury is dependent on N-methyl-D-aspartate receptor activation. Neurosurg 1995;37:1080-1087.
32. Royblat L, Korotkoruchko A, Katz J, Glazer M, Greemberg L, Fisher A: Postoperative pain: The effect of low-dose ketamine in addition to general anesthesia. Anesth Analg 1993;77:1161-1165.
33. Tverskoy M, Oz Y, Isakson A, Finger J, Bradley EL, Kissin I: Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia. Anesth Analg 1994;78:205-209.
34. Rogawski MA: Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 1993;14:325-331.
35. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB: High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997;48:1212-1218.
36. McQuay H, Carroll D, Jahad A, Glynn CJ, Jack T, Moore RA, Wiffen PJ: Dextromethorphan for the treatment of neuropathic pain: a double-blind randomized controlled crossover trial with integral n-of-1 design. Pain 1994;59:127-133.
37. Cooper SA, Beaver WT: A model to evaluate mild analgesics in oral surgery outpatients. Clin Pharmacol Ther 1976;20:241-250.
38. Hargreaves KM, Dionne RA: Evaluating endogenous mediators of pain and analgesia in clinical studies. In, Max M, Portenoy R, Laska E (eds.): The Design of Analgesic Trials. New York: Raven Press, 1991;579-598.
39. Dionne RA: Evaluation of analgesic mechanisms and NSAIDs for acute pain using the oral surgery model. In, Rainsford KD, Powanda MC (eds.): Safety and Efficacy of Non-Prescription (OTC) Analgesics and NSAIDs. New York: Kluwer Academic Publishers, 1998;105-117.
40. Sessle BJ: Masticatory muscle disorders: basic science perspective. In, Sessle BJ, Bryant PS, Dionne RA (eds.): Temporomandibular Disorders and Related Pain Conditions. Seattle: IASP Press, 1995; 47-61.
41. Gordon SM, Dionne RA, Brahim J, Jabir F, Dubner R: Blockade of peripheral neuronal barrage reduces postoperative pain. Pain 1997;70:209-215.
42. Gordon SM, Dionne RA, Brahim JS, Sang CN, DubnerR: Differential effects of local anesthesia on central hyperalgesia. J Dent Res 1997;76:153.
43. Gracely R, Dubner R: Reliability and validity of verbal descriptor scales of painfulness. Pain 1987;29:175-185.
44. Berthold CW, Dionne RA: Clinical evaluation of H1 receptor and H2 receptor antagonists for acute postoperative pain. J Clin Pharmacol 1993;33:944-948.
45. Ilkjaer S, Dirks J, Brennum J, Wernberg M, Dahl JB: Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans. Br J Anaesth 1997;79:600-605.
46. Kauppila T, Gronroos M, Pertovaara A: An attempt to attenuate experimental pain in humans by dextromethorphan, an NMDA receptor antagonist. Pharmacol Biochem Behav 1995;52:641-644.
47. Bem JL, Peck R: Dextromethorphan: an overview of safety issues. Drug Safety 1992;7:190-199.